Portal:CPTAC/Hallmarks
From WikiPathways
(Difference between revisions)
(New page: {| style="margin: 10px; background-color:#eaf2ee" |width=100px; cell padding=50px; style="text-align:center;"|'''Sustaining proliferative signaling''' {{#pwImage:Pathway:WP2868|250px||TCA ...) |
Current revision (18:59, 5 October 2017) (view source) (added Therapeutics category) |
||
| (8 intermediate revisions not shown.) | |||
| Line 1: | Line 1: | ||
| - | {| style="margin: 10px; background-color:#eaf2ee" | + | {| style="width:100%; margin: 10px; background-color:#eaf2ee" |
| - | |width=100px; cell padding=50px; style="text-align:center;"| | + | |width=100px; cell padding=50px; style="text-align:center;"|[[Portal:CPTAC/Hallmark/Proliferative|<big><u><b>Sustaining proliferative signaling</b></u></big>]] {{ #pathwayOfTheDay: {{LOCALDAYNAME}} {{LOCALDAY}} {{LOCALMONTHNAME}} {{LOCALYEAR}} | Portal:CPTAC/Hallmark/Proliferative}} |
| - | |width=100px; style="text-align:center;"| | + | |width=100px; style="text-align:center;"|[[Portal:CPTAC/Hallmark/Growth|<big><u><b>Evading growth suppressors</b></u></big>]] {{ #pathwayOfTheDay: {{LOCALDAYNAME}} {{LOCALDAY}} {{LOCALMONTHNAME}} {{LOCALYEAR}} | Portal:CPTAC/Hallmark/Growth}} |
| - | |width=100px; style="text-align:center;"| | + | |width=100px; style="text-align:center;"|[[Portal:CPTAC/Hallmark/Invasion|<big><u><b>Activating invasion and metastasis</b></u></big>]] {{ #pathwayOfTheDay: {{LOCALDAYNAME}} {{LOCALDAY}} {{LOCALMONTHNAME}} {{LOCALYEAR}} | Portal:CPTAC/Hallmark/Invasion}} |
| - | + | ||
|- | |- | ||
| - | |width=100px|{{# | + | |width=100px; style="text-align:center;"|[[Portal:CPTAC/Hallmark/immortality|<big><u><b>Enabling replicative immortality</b></u></big>]] {{ #pathwayOfTheDay: {{LOCALDAYNAME}} {{LOCALDAY}} {{LOCALMONTHNAME}} {{LOCALYEAR}} | Portal:CPTAC/Hallmark/immortality}} |
| - | |width=100px|{{# | + | |width=100px; style="text-align:center;"|[[Portal:CPTAC/Hallmark/Angiogenesis|<big><u><b>Inducing angiogenesis</b></u></big>]] {{ #pathwayOfTheDay: {{LOCALDAYNAME}} {{LOCALDAY}} {{LOCALMONTHNAME}} {{LOCALYEAR}} | Portal:CPTAC/Hallmark/Angiogenesis}} |
| - | |width=100px|{{# | + | |width=100px; style="text-align:center;"|[[Portal:CPTAC/Hallmark/Resisting|<big><u><b>Resisting cell death</b></u></big>]] {{ #pathwayOfTheDay: {{LOCALDAYNAME}} {{LOCALDAY}} {{LOCALMONTHNAME}} {{LOCALYEAR}} | Portal:CPTAC/Hallmark/Resisting}} |
| - | |width=100px|{{# | + | |- |
| + | |width=100px; style="text-align:center;"|[[Portal:CPTAC/Hallmark/Deregulating|<big><u><b>Deregulating cellular energetics</b></u></big>]] {{ #pathwayOfTheDay: {{LOCALDAYNAME}} {{LOCALDAY}} {{LOCALMONTHNAME}} {{LOCALYEAR}} | Portal:CPTAC/Hallmark/Deregulating}} | ||
| + | |width=100px; style="text-align:center;"|[[Portal:CPTAC/Hallmark/Instability|<big><u><b>Genome instability and mutation</b></u></big>]] {{ #pathwayOfTheDay: {{LOCALDAYNAME}} {{LOCALDAY}} {{LOCALMONTHNAME}} {{LOCALYEAR}} | Portal:CPTAC/Hallmark/Instability}} | ||
| + | |width=100px; style="text-align:center;"|[[Portal:CPTAC/Hallmark/Inflammation|<big><u><b>Tumor promoting inflammation</b></u></big>]] {{ #pathwayOfTheDay: {{LOCALDAYNAME}} {{LOCALDAY}} {{LOCALMONTHNAME}} {{LOCALYEAR}} | Portal:CPTAC/Hallmark/Inflammation}} | ||
| + | |- | ||
| + | |width=100px; style="text-align:center;"|[[Portal:CPTAC/Hallmark/Avoiding|<big><u><b>Avoiding immune destruction</b></u></big>]] {{ #pathwayOfTheDay: {{LOCALDAYNAME}} {{LOCALDAY}} {{LOCALMONTHNAME}} {{LOCALYEAR}} | Portal:CPTAC/Hallmark/Avoiding}} | ||
| + | |width=100px; style="text-align:center;"|[[Portal:CPTAC/Hallmark/Therapeutics|<big><u><b>Therapeutics</b></u></big>]] {{ #pathwayOfTheDay: {{LOCALDAYNAME}} {{LOCALDAY}} {{LOCALMONTHNAME}} {{LOCALYEAR}} | Portal:CPTAC/Hallmark/Therapeutics}} | ||
|} | |} | ||
Current revision
| Sustaining proliferative signaling
ErbB signaling (Homo sapiens) Image does not exist ErbB signaling | Evading growth suppressors
G1 to S cell cycle control (Homo sapiens) Image does not exist G1 to S cell cycle control | Activating invasion and metastasis
H19, Rb-E2F1, and CDK-beta-catenin in colorectal cancer (Homo sapiens) Image does not exist H19, Rb-E2F1, and CDK-beta-catenin in colorectal cancer |
| Enabling replicative immortality
ncRNAs in Wnt signaling in hepatocellular carcinoma (Homo sapiens) Image does not exist ncRNAs in Wnt signaling in hepatocellular carcinoma | Inducing angiogenesis
Angiogenesis (Homo sapiens) Image does not exist Angiogenesis | Resisting cell death
PI3K-AKT-mTOR signaling and therapeutic opportunities in prostate cancer (Homo sapiens) Image does not exist PI3K-AKT-mTOR signaling and therapeutic opportunities in prostate cancer |
| Deregulating cellular energetics
Target of rapamycin signaling (Homo sapiens) Image does not exist Target of rapamycin signaling | Genome instability and mutation
ATR signaling (Homo sapiens) Image does not exist ATR signaling | Tumor promoting inflammation
IL6 signaling (Homo sapiens) Image does not exist IL6 signaling |
| Avoiding immune destruction
Altered glycosylation of MUC1 in tumor microenvironment (Homo sapiens) Image does not exist Altered glycosylation of MUC1 in tumor microenvironment | Therapeutics
Photodynamic therapy-induced NF-kB survival signaling (Homo sapiens) Image does not exist Photodynamic therapy-induced NF-kB survival signaling |
